Large Absolute Benefit of PCSK9 Inhibition in ACS With Polyvascular Disease - Endocrinology Advisor
Large Absolute Benefit of PCSK9 Inhibition in ACS With Polyvascular Disease Endocrinology Advisor
Polyvascular disease is associated with high risks of major adverse cardiovascular events and death despite intensive statin therapy.
Comments
Post a Comment